Optiver Holding’s MaxCyte MXCT Stock Holding History

Optiver Holding’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Sell	3 -1,600	-100%	-$1.59K	﹤0.01%	2743
2026 Q1	$1.13K	Hold	1,603	–	–	﹤0.01%	2039
2025 Q4	$2.48K	Hold	1,603	–	–	﹤0.01%	1888
2025 Q3	$2.53K	Hold	1,603	–	–	﹤0.01%	2281
2025 Q2	$3.5K	Buy	1,603 +712	+80%	+$1.72K	﹤0.01%	1271
2025 Q1	$2.43K	Buy	891 +458	+106%	+$1.81K	﹤0.01%	1215
2024 Q4	$1.8K	Buy	433 +110	+34%	+$416	﹤0.01%	954
2024 Q3	$1.26K	Sell	323 -464	-59%	-$1.96K	﹤0.01%	891
2024 Q2	$3.08K	Buy	787 +211	+37%	+$908	﹤0.01%	825
2024 Q1	$2.41K	Buy	+576	New	+$2.7K	﹤0.01%	656

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Optiver Holding's MXCT Position: Q2 2026 in Review

Optiver Holding reduced its MaxCyte (MXCT) stake by 100% in Q2 2026, selling an estimated $1.59K and leaving 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Optiver Holding first reported a position in MXCT in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.5K in Q2 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Optiver Holding held 3 shares of MaxCyte worth $4 as of Q2 2026.
Optiver Holding sold 1,600 MaxCyte shares in Q2 2026, an estimated $1.59K.
MaxCyte made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2743 holding.
Optiver Holding first reported a position in MaxCyte in Q1 2024 and has held it in 10 quarters since.
Optiver Holding's MaxCyte position peaked at $3.5K in Q2 2025.
122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.